Squamous Cell Carcinoma of the Hypopharynx

• CLINICAL_TRIALS research · 2026-03-13
  Clinical Trial Update: De-Intensification of Postoperative Radiotherapy in Patients With Squamous Cell Carcinoma of the Head and Neck [Phase 2, Phase 3]

  A Phase 2/Phase 3 trial is evaluating de-intensification of postoperative radiotherapy for head and neck squamous cell carcinomas, including…

• CLINICAL_TRIALS research · 2026-02-10
  Clinical Trial Update: Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck [NA]

  This clinical trial update indicates that a study evaluating transoral robotic surgery for benign or malignant head and neck tumors is curre…

• CLINICAL_TRIALS research · 2025-02-26
  Clinical Trial Update: Fluorescence-guided Surgery in Laryngeal- and Hypopharyngeal Cancer: a Feasibility Trial [Phase 2]

  A Phase 2 feasibility trial evaluating fluorescence-guided surgery for squamous cell carcinoma of the larynx and hypopharynx; the study is c…

• CLINICAL_TRIALS research · 2024-11-13
  Clinical Trial Update: Head and Neck Carcinoma Clinical Research Platform for Molecular and Blood-based Biomarkers, Treatment and Outcome

  Clinical trial platform in head and neck carcinoma focusing on molecular and blood-based biomarkers, treatment, and outcomes is currently re…

• CLINICAL_TRIALS research · 2024-09-26
  Clinical Trial Update: SBRT Followed by Chemoimmunotherapy of Toripalimab Plus Docetaxel and Cisplatin for Larynx Preservation in Patients with Locally Regionally Advanced Squamous Cell Carcinoma of the Larynx and Hypopharynx [Phase 2]

  A Phase 2 trial evaluating SBRT followed by chemoimmunotherapy with toripalimab, docetaxel, and cisplatin to preserve the larynx in patients…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2022-12-20
  Clinical Trial Update: Cetuximab & Nivolumab in Patients With Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma [Phase 1, Phase 2]

  A Phase 1/2 study evaluating the combination of cetuximab and nivolumab in recurrent or metastatic head and neck squamous cell carcinoma has…

• CLINICAL_TRIALS trial_result · 2022-05-26
  Clinical Trial Update: Induction Chemotherapy With TP+5-FU or TP+Cetuximab Followed by Radioimmuptherapy for Locally Advanced or Not Resectable SCCHNN [Phase 2]

  Phase 2 trial evaluating induction TP+5-FU or TP+cetuximab followed by radioimmunotherapy for locally advanced or unresectable squamous cell…

• CLINICAL_TRIALS trial_result · 2020-05-12
  Clinical Trial Update: Erlotinib Hydrochloride and Radiation Therapy in Stage III-IV Squamous Cell Cancer of the Head and Neck [Phase 2]

  Phase 2 trial evaluating erlotinib hydrochloride with radiation therapy in various Stage III-IV squamous cell carcinomas of the head and nec…

• CLINICAL_TRIALS trial_result · 2020-05-01
  Clinical Trial Update: Parenteral Nutrition for Patients Treated for Locally Advanced Inoperable Tumors of the Head and Neck [Phase 3]

  Phase 3 clinical trial investigating parenteral nutrition for patients treated for locally advanced inoperable head and neck squamous cell c…

• CLINICAL_TRIALS trial_result · 2020-03-19
  Clinical Trial Update: Capecitabine and Lapatinib Ditosylate in Treating Patients With Squamous Cell Cancer of the Head and Neck [Phase 2]

  Phase 2 clinical trial evaluating capecitabine and lapatinib ditosylate in various forms of head and neck squamous cell carcinoma has comple…

• CLINICAL_TRIALS trial_result · 2018-08-14
  Clinical Trial Update: Paclitaxel and Carboplatin Before Radiation Therapy With Paclitaxel in Treating HPV-Positive Patients With Stage III-IV Oropharynx, Hypopharynx, or Larynx Cancer [Phase 2]

  Phase 2 trial evaluating paclitaxel and carboplatin before radiation therapy in HPV-positive Stage III-IV oropharynx, hypopharynx, or larynx…

• CLINICAL_TRIALS trial_result · 2016-01-27
  Clinical Trial Update: Adaptive, Image-guided, Intensity-modulated Radiotherapy for Head and Neck Cancer in the Reduced Volumes of Elective Neck [Phase 2]

  Phase 2 trial investigating adaptive, image-guided radiotherapy with intensity-modulated radiotherapy for head and neck squamous cell carcin…

• CLINICAL_TRIALS trial_result · 2015-05-19
  Clinical Trial Update: Depsipeptide in Unresectable Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck [Phase 2]

  Phase 2 clinical trial update for depsipeptide in unresectable recurrent or metastatic squamous cell carcinoma of the head and neck; study c…

• CLINICAL_TRIALS trial_result · 2015-04-15
  Clinical Trial Update: Lapatinib Ditosylate in Treating Patients With Metastatic or Recurrent Head and Neck Cancer [Phase 2]

  A Phase 2 trial evaluating lapatinib ditosylate in patients with metastatic or recurrent head and neck cancer has been completed.

• CLINICAL_TRIALS withdrawal · 2013-11-08
  Clinical Trial Update: S0225 Capecitabine in Treating Patients Who Have Undergone Surgery for Locally Recurrent or Persistent Head and Neck Cancer [Phase 2]

  The Phase 2 trial S0225 evaluating capecitabine in patients who underwent surgery for locally recurrent or persistent head and neck squamous…

• CLINICAL_TRIALS trial_result · 2013-01-25
  Clinical Trial Update: Gefitinib and Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III or Stage IV Head and Neck Cancer [Phase 1]

  Phase 1 trial assessing gefitinib with radiation therapy, with or without cisplatin, for Stage III or Stage IV head and neck squamous cell c…

• CLINICAL_TRIALS trial_result · 2013-01-24
  Clinical Trial Update: Intratumoral PV701 in Treating Patients With Advanced or Recurrent Unresectable Squamous Cell Carcinoma of the Head and Neck [Phase 1]

  Phase 1 trial update on intratumoral PV701 for patients with advanced or unresectable recurrent squamous cell carcinoma of the head and neck…

• CLINICAL_TRIALS trial_result · 2012-12-27
  Clinical Trial Update: Bortezomib With or Without Irinotecan in Treating Patients With Locally Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck [Phase 2]

  Phase 2 trial evaluating bortezomib with or without irinotecan in locally recurrent or metastatic squamous cell carcinoma of the head and ne…